| Smouldering multiple sclerosis: the ‘real MS’ G Giovannoni, V Popescu, J Wuerfel, K Hellwig, E Iacobaeus, MB Jensen, ... Therapeutic advances in neurological disorders 15, 17562864211066751, 2022 | 172 | 2022 |
| Impairment of social cognition in multiple sclerosis: Amygdala atrophy is the main predictor S Batista, OC d’Almeida, A Afonso, S Freitas, C Macário, L Sousa, ... Multiple Sclerosis Journal 23 (10), 1358-1366, 2017 | 83 | 2017 |
| The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis S Freitas, S Batista, AC Afonso, MR Simões, L de Sousa, L Cunha, ... Applied Neuropsychology: Adult 25 (1), 57-70, 2018 | 76 | 2018 |
| Pregnancy in multiple sclerosis: a Portuguese cohort study J Jesus-Ribeiro, I Correia, AI Martins, M Fonseca, I Marques, S Batista, ... Multiple sclerosis and related disorders 17, 63-68, 2017 | 57 | 2017 |
| Disconnection as a mechanism for social cognition impairment in multiple sclerosis S Batista, C Alves, OC d’Almeida, A Afonso, R Félix-Morais, J Pereira, ... Neurology 89 (1), 38-45, 2017 | 54 | 2017 |
| Efficacy and safety of alemtuzumab through 9 years of follow-up in patients with highly active disease: post hoc analysis of CARE-MS I and II patients in the TOPAZ extension study T Ziemssen, AD Bass, R Berkovich, G Comi, S Eichau, J Hobart, ... CNS drugs 34, 973-988, 2020 | 47 | 2020 |
| Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI IB Marques, F Matias, ED Silva, L Cunha, L Sousa Journal of Clinical Neuroscience 21 (4), 583-586, 2014 | 41 | 2014 |
| Variations in multiple sclerosis practice within Europe–Is it time for a new treatment guideline? M Marziniak, K Ghorab, W Kozubski, C Pfleger, L Sousa, K Vernon, ... Multiple sclerosis and related disorders 8, 35-44, 2016 | 40 | 2016 |
| Plasma exchange in severe acute relapses of multiple sclerosis–Results from a Portuguese cohort I Correia, JJ Ribeiro, L Isidoro, S Batista, C Nunes, C Macário, C Borges, ... Multiple sclerosis and related disorders 19, 148-152, 2018 | 39 | 2018 |
| Encephalopathy associated with autoimmune thyroid disease: a potentially reversible condition I Correia, IB Marques, R Ferreira, L Sousa Case reports in medicine 2016 (1), 9183979, 2016 | 33 | 2016 |
| Theory of mind and executive functions are dissociated in multiple sclerosis S Batista, S Freitas, A Afonso, C Macário, L Sousa, L Cunha, I Santana Archives of Clinical Neuropsychology 33 (5), 541-551, 2018 | 31 | 2018 |
| The neural basis of fatigue in multiple sclerosis: a multimodal MRI approach AM Novo, S Batista, C Alves, OC d’Almeida, IB Marques, C Macário, ... Neurology: Clinical Practice 8 (6), 492-500, 2018 | 29 | 2018 |
| Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years J Oh, A Achiron, EG Celius, C Chambers, J Derwenskus, V Devonshire, ... Multiple Sclerosis and Related Disorders 43, 102146, 2020 | 27 | 2020 |
| The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study M Branco, I Alves, A Martins da Silva, J Pinheiro, MJ Sá, I Correia, ... BMC neurology 20, 1-7, 2020 | 21 | 2020 |
| Apathy in multiple sclerosis: gender matters AM Novo, S Batista, J Tenente, C Nunes, C Macário, L Sousa, ... Journal of Clinical Neuroscience 33, 100-104, 2016 | 21 | 2016 |
| The effectiveness of fingolimod in a Portuguese real-world population I Correia, S Batista, IB Marques, M Sousa, R Ferreira, C Nunes, ... Multiple Sclerosis and Related Disorders 6, 41-48, 2016 | 21 | 2016 |
| Multiple sclerosis: association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the disease A Valado, MJ Leitão, A Martinho, R Pascoal, J Cerqueira, I Correia, ... Multiple sclerosis and related disorders 11, 71-76, 2017 | 19 | 2017 |
| Anti-JCV antibody serostatus and longitudinal evaluation in a Portuguese Multiple Sclerosis population I Correia, J Jesus-Ribeiro, S Batista, AI Martins, C Nunes, MC Macário, ... Journal of Clinical Neuroscience 45, 257-260, 2017 | 18 | 2017 |
| Clinical predictors of an optimal response to natalizumab in multiple sclerosis J Sargento-Freitas, S Batista, C Macario, F Matias, L Sousa Journal of Clinical Neuroscience 20 (5), 659-662, 2013 | 17 | 2013 |
| Alemtuzumab outcomes by age: post hoc analysis from the randomized CARE-MS studies over 8 years AD Bass, R Arroyo, AL Boster, AN Boyko, S Eichau, C Ionete, V Limmroth, ... Multiple Sclerosis and Related Disorders 49, 102717, 2021 | 16 | 2021 |
Sonia BatistaNeurologistVerified email at huc.min-saude.pt
